Nordic NanoVector's IPO

Nordic NanoVector raised a round of funding on July 07, 2014. Investors include Public.

Nordic Nanovector is focusing on the development and commercialization of novel targeted therapeutics for haematological cancers. The Company's lead clinical-stage product opportunity is Betalutin, th…

Articles about Nordic NanoVector's IPO: